Schedule 13D ownership disclosure

VOR BIOPHARMA INC

Security class unavailable · CUSIP: 929033108

Event date: 2023-08-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
22,780,343
Percent of class
33.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-090590
Form type
SC 13D/A
Filer
RA CAPITAL MANAGEMENT, L.P.
CIK
CIK 1346824
Filed
Aug 11, 2023
Reporting period
Aug 10, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub